SAN JUAN CAPISTRANO, Calif., April 18 /PRNewswire-FirstCall/ -- Clarient, Inc. , will report its 2006 first quarter results before the stock market opens on Wednesday, April 26, 2006. That same day management will host a conference call that will be broadcast live on the Internet at 11:30 a.m. (EST) to discuss results of operations.
Interested participants may access the live webcast on the Investor page under the Upcoming Events section on the Company’s website (www.clarientinc.com/investor). Webcast listeners will be able to submit questions by emailing nathan@allencaron.com or clicking on the email address provided on the webcast page. Web participants are encouraged to go to the website at least 15 minutes prior to the start of the call to register and download and install any necessary audio software. For those unable to participate during the live broadcast, the webcast will be archived shortly after the call and will be available for one year.
About Clarient Inc.
Clarient combines innovative technologies with world class expertise to assess and characterize cancer. Clarient’s mission is to provide technologies, services and the critical information to improve the quality and reduce the cost of patient care as well as accelerating the drug development process. The Company’s principal customers include pathologists, oncologists, hospitals and biopharmaceutical companies. For more information, visit www.clarientinc.com.
About Safeguard
Safeguard Scientifics, Inc. builds value in high-growth, revenue-stage information technology and life sciences businesses. Safeguard provides growth capital as well as a range of strategic, operating and management resources to our partner companies. The company participates in expansion financings, corporate carve-outs, management buyouts, recapitalizations, industry consolidations and early-stage financings. For more information about Safeguard, please visit www.safeguard.com.
Contact: Roberta L. Smigel Clarient, Inc. (949) 443.3355 investorrelations@clarientinc.com
Clarient Inc.
CONTACT: Roberta L. Smigel of Clarient, Inc., +1-949-443-3355,investorrelations@clarientinc.com
